Skip to main content
medichelpline
Join Free
Back to Drug Index
General MedicationsORALGeneric

ILOSONE SULFA

ERYTHROMYCIN ESTOLATE; SULFISOXAZOLE ACETYL

Standard Dose
EQ 125MG BASE/5ML;EQ 600MG BASE/5ML
Max Dose
Refer to approved labeling
Primary Use
Marketing status: Discontinued

Key Takeaways

  • Primary indication: Marketing status: Discontinued
  • Approval overview ILOSONE SULFA is listed in Drugs@FDA under application 050599 (NDA).
  • Marketing status: Discontinued Active ingredient ERYTHROMYCIN ESTOLATE; SULFISOXAZOLE ACETYL Form and strength SUSPENSION;ORAL - EQ 125MG BASE/5ML;EQ 600MG BASE/5ML Sponsor LILLY Submission history See approval history documents.

Structured Monograph

Clinical summary

Approval overview ILOSONE SULFA is listed in Drugs@FDA under application 050599 (NDA). Marketing status: Discontinued Active ingredient ERYTHROMYCIN ESTOLATE; SULFISOXAZOLE ACETYL Form and strength SUSPENSION;ORAL - EQ 125MG BASE/5ML;EQ 600MG BASE/5ML Sponsor LILLY Submission history See approval history documents.

Monitoring

  • • Marketing status: Discontinued

Interaction Notes

  • No interaction notes stored yet.